Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Clazosentan

Generic Name: Clazosentan

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₃N_₉O_₆S

CAS Number: 180384-56-9

Unique Ingredient Identifier: 3DRR0X4728

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in strokes.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study in Healthy Subjects to Investigate Whether Administration of Clazosentan Can Affect Normal Heart Function

Phase 1

Completed

Posted: 2018/09/05

Sponsor:Idorsia Pharmaceutic...

ID:NCT03657446

A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

Phase 1

Completed

Posted: 2018/07/23

Sponsor:Idorsia Pharmaceutic...

ID:NCT03596294

Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain

Phase 3

Completed

Posted: 2018/07/12

Sponsor:Idorsia Pharmaceutic...

ID:NCT03585270

Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage

Phase 2

Completed

Posted: 2015/09/25

Sponsor:Idorsia Pharmaceutic...

ID:NCT02560532

Clazosentan in Aneurysmal Subarachnoid Hemorrhage

Phase 3

Terminated

Posted: 2009/07/15

Sponsor:Idorsia Pharmaceutic...

ID:NCT00940095

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy